2008 U.S. Food and Drug Administration Critical Path Workshop. Clinical trials for local treatment of breast cancer by thermal ablation

 


Quick Links

Critical Path Initiative

Invited Discussant Bios

Timothy Whelan, B.M., B.Ch., M.Sc., FRCP

Tim Whelan is head of the Radiation Therapy Program at the Hamilton Health Sciences Juravinski Cancer Centre, Professor in the Department of Oncology, and Associate Member of the Department of Clinical Epidemiology and Biostatistics at McMaster University. He is co-chair of the Breast Disease Site Group of the NCIC Clinical Trials Group and Director of the Supportive Cancer Care Research Unit, a health system-linked research unit sponsored by the Ontario Ministry of Health and Long-Term Care. Dr. Whelan obtained his medical degree at the University of Oxford and received his post-graduate training at the University of Toronto. From 1991 to 1993, he was a Terry Fox Research Fellow at McMaster University. Since 1993, his research has focused on clinical trials in radiation oncology and health services research in cancer, particularly in supportive care, quality of life, and shared physician-patient decision-making. In April 2001, he was awarded a Canada Research Chair in Breast Cancer with renewal in 2006. He is known for his work evaluating novel approaches for radiation therapy in breast cancer and the development and evaluation of decision aids to facilitate communication between doctors and patients regarding treatment decisions.

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 
Sponsored by the FDA: September 15, 2008 | FDA White Oak Campus | Building 21 | 10903 New Hampshire Avenue | Silver Spring, MD 20993
Register Online Now!  Registration Quick Link